PASITHEA THERAPEUTICS CORP. Payments for Repurchase of Equity
PASITHEA THERAPEUTICS CORP. (KTTA) had Payments for Repurchase of Equity of $4.00 million as of 2023-07-20, per its 10-Q filed 2024-11-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsForRepurchaseOfEquity · last filed 2024-11-13
- 2023-07-20: Payments for Repurchase of Equity $4.00M.
| Period end | Payments for Repurchase of Equity |
|---|---|
| 2023-07-20 | $4.00M 10-Q · filed 2024-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Rocket One Inc. (RKTO) | United States | $0.019B |